Designing For Alzheimer S Disease

Designing for Alzheimer's Disease offers a complete blueprint for effective design development and implementation, with the full benefit of Elizabeth Brawley's extensive professional background in design for aging environments and her own family's experience with Alzheimer's disease.

This book presents the latest research that shows how design thinking, making, and acting contribute to the co-designing and development of products, spaces, and services with people living with dementia. We know that there is currently no cure for the 130+ kinds of dementia that millions of people live with all over the world, but the designed interventions such as the products, spaces, and services described in this book can address stigma, isolation, loss of confidence, and raise awareness and greater understanding of dementia. This book showcases a range of innovative and creative design interventions that have been developed to break the cycle of well-established opinions, strategies, mindsets, and ways of doing that tend to remain unchallenged in the health and social care of people living with dementia. The book will be of interest to scholars working in product design, service design, experience design, architecture, design research, information design, user-centred design, and design for health.

As our understanding of aging and Alzheimer's, and the cultural changes related to these phenomena, grows so do the implications for interior design. Focus on recent innovations in care environments for the aging with a resource dedicated to this topic. This comprehensive book features: Coverage of the emerging building types of adult day care and hospice and the increased use of gardens and outdoor space in environments for the aging. Material on sustainable design and environmentally friendly building products. Design solutions that extend beyond assisted-living facilities and nursing homes as they can be easily adapted for residential use. Photographs, line drawings, and a 16-page color insert that bring the material to life. Order your copy of this book today.

The ebook edition of this title is Open Access and is freely available to read online. This book systematically explores and assesses the quality of the evidence base for effective and supportive design of living environments for people living with Dementia.

In this pioneering book in the newly emerging field of architectural design and dementia, Uriel Cohen and Gerald Weisman set forth a program of practical design principles linked to specific therapeutic goals. People with dementia live in environments ranging from their own homes to community-based group homes and long-term care facilities. Holding On to Home addresses key issues for the planning and modification of all these settings. The book is equally useful to caregivers, nursing home and adult day care planners and administrators, architects, and interior designers, as well as to students and practitioners of geriatrics and gerontology.

Dementia is increasingly and widely recognised as a serious health and social challenge, in the developed world as well as in the developing world. The need therefore to design and implement dementia care services of high quality is becoming more and more vital, particularly given the likelihood of ever increasing demand in a world, which likely sees resources at best remaining at current levels. Designing and Delivering Dementia Services describes current developments in the design and configuration of dementia services. It offers an informative and detailed overview of what constitutes high quality care, considering the circumstances patients and carers may find themselves in. For dementia to get the priority it deserves, a number of factors are important and the book charts the invaluable contributions of various Alzheimer's Associations and Societies: this provides a focus on dementia strategies and plans at national levels: the book reports on the state of affairs regarding such strategies and provides a unique insight into the process of how one of these was developed and implemented. Recognising the need to prove that service developments lead to a higher quality of care, increased productivity and increased efficiency, the book links the resulting picture to service-based research methodologies, with an emphasis on the strengths and limitations of that research. Contributions from 17 countries on 4 continents give an overview of the state of affairs across the world, paying attention to successful - and less successful - initiatives to improve dementia care. The book furthermore provides pragmatic approaches to ensure planning becomes reality, highlights the need for structured workforce development, education and training and describes the opportunities afforded by assistive technology. This book is of prime informative and practical value given that pressures on dementia services are projected to mount across the world against a backdrop of limited resources and expertise. Designing and Delivering Dementia Services Defines the problems involved in meeting an increasing demand for dementia care services in a poorer world Maps initiatives and developments in the design and configuration of these services in a variety of international settings Analyses these developments against the background of political and health economic circumstances Provides a road map of where health services should go in response to this growing challenge. The first book to define, analyse and map initiatives for dementia care services in a time of increasing demand and decreasing resources, this book is essential reading for commissioners, senior clinicians and service planners in health and social care. It will also be of interest to academic researchers involved in qualitative services research as well as quantitative health economic research, health and social care managers and those involved in workforce planning and development.

Drug Design and Discovery in Alzheimer’s Disease includes expert reviews of recent developments in Alzheimer's disease (AD) and neurodegenerative disease research. Originally published by Bentham as Frontiers in Drug Design and Discovery, Volume 6and now distributed by Elsevier, this compilation of the sixteen articles, written by leading global researchers, focuses on key developments in the understanding of the disease at molecular levels, identification and validation of molecular targets, as well as innovative approaches towards drug discovery, development, and delivery. Beginning with an overview of AD pharmacotherapy and existing blockbuster drugs, the reviews cover the potential of both natural and synthetic small molecules; the role of cholinesterases in the on-set and progression of AD and their inhibition; the role of beta-site APP clearing enzyme-1 (BACE-1) in the production of ß-amyloid proteins, one of the key reasons of the progression of AD; and other targets identified for AD drug discovery. Edited and written by leading experts in Alzheimer’s disease (AD) and other neurodegenerative disease drug development Describes existing drugs for AD and current molecular understanding of the condition Reviews recent advances in the field, including coverage of cholinesterases, BACE-1, and other drug development targets